Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate

Journal of Virology(2023)10.1128/jvi.01900-22Source: DataRank Database

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate is a research paper published in Journal of Virology (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.55)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Bin Luo ORCID,Zhiyun Wen,Lan Zhang ORCID,Eberhard Dürr ORCID,Trudy G. Morrison ORCID

Live enrichment

PubMed:36602367 PMC:PMC9888267 OpenAlex:https://openalex.org/W4313544991

HHS | National Institutes of Health

Grant: AI043896

NIAID NIH HHS

Grant: R01 AI143896

National Institutes of Health

Grant: 5R01AI043896-05

REVERSE TRANSCRIPTASE AND OTHER HIV MOLECULAR STRUCTURES

Merck

FWCI

4.55

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9888267/pdf/jvi.01900-22.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.01900-22

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9888267

journalhttps://doi.org/10.1128/jvi.01900-22

Fields of Study

Respiratory viral infections researchAnimal Virus Infections StudiesVirology and Viral Diseases0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsAntibodies, ViralGlycoproteinsHumansViral ProteinsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesMiceAntibodies, NeutralizingVaccines, Virus-Like Particle

Keywords

BiologyVirologyVirusVirus-like particleImmune systemViral envelopeImmunologyRecombinant DNAGeneGeneticsImmunizationVaccineG proteinsRespiratory syncytial virusF proteinVLPsRespiratory Syncytial Virus InfectionsAntibodies, ViralAntibodies, NeutralizingMiceViral ProteinsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus VaccinesAnimalsHumansVaccines, Virus-Like ParticleGlycoproteins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being